Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,284 across all filing types
Latest filing 2025-11-28 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
独立董事候选人关于参加最近一次独立董事培训并取得独立董事资格证书的承诺
Board/Management Information Classification · 95% confidence The document is a company announcement regarding the nomination of an independent director candidate and his commitment to obtain the required independent director qualification certificate. It references compliance with regulatory guidelines for independent directors and includes a formal commitment statement. There is no financial data, no report or presentation, no voting results, no legal proceedings, and no other financial or governance report content. This type of announcement about board member qualifications and related compliance fits best under Board/Management Information (MANG). The document length is short and focused on management/board information rather than a full report or regulatory filing.
2025-11-28 Chinese
第五届董事会第三十次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of 瑞普生物股份有限公司 (Ruipu Bio Co., Ltd.). It details the nomination of candidates for the new board, amendments to the company charter, revisions to internal control systems, and the scheduling of a shareholders meeting. The content focuses on board and governance matters, including board member nominations and internal governance rules. There is no financial data or earnings information, nor is it a report or presentation. The document is not a proxy solicitation or voting results announcement but rather a board meeting resolution announcement. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2025-11-28 Chinese
董事会战略委员会工作细则（2025年11月）
Governance Information Classification · 95% confidence The document is titled '董事会战略委员会工作细则' which translates to 'Board Strategic Committee Working Rules'. It details the composition, responsibilities, decision-making procedures, and meeting rules of the Board's Strategic Committee. There is no financial data, no mention of financial results, no shareholder voting results, no legal proceedings, no capital changes, and no report publication. The content focuses on governance structure and internal board committee rules. Therefore, it fits best under Governance Information (CGR). The document length is short (1977 characters), but it is not an announcement or a brief notice; it is a detailed governance document.
2025-11-28 Chinese
对外提供财务资助管理制度（2025年11月）
Governance Information Classification · 95% confidence The document is titled as a management system or policy document regarding the company's external financial assistance management. It outlines rules, procedures, responsibilities, and disclosure requirements related to providing financial support to external parties. It references regulatory frameworks and internal governance but does not contain financial statements, earnings data, or audit results. It is a governance-related internal control document rather than a report or announcement of financial results or capital changes. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-11-28 Chinese
风险投资管理制度（2025年11月）
Governance Information Classification · 95% confidence The document is titled '风险投资管理制度' which translates to 'Risk Investment Management System' and contains detailed internal rules and procedures for managing the company's risk investment activities. It references relevant laws, regulatory rules, and internal governance structures. The content is a policy or governance document outlining decision-making authority, disclosure obligations, organizational responsibilities, and operational procedures related to risk investments. It does not contain financial statements, audit opinions, earnings data, or shareholder meeting materials. It is not an announcement or a brief summary but a comprehensive governance framework document. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-11-28 Chinese
内部问责制度（2025年11月）
Governance Information Classification · 95% confidence The document is titled '内部问责制度' which translates to 'Internal Accountability System' for 瑞普生物股份有限公司 (Rip Bio Co., Ltd.). It outlines the company's internal governance rules, accountability mechanisms, procedures for holding directors and senior management accountable, and related disciplinary measures. The content focuses on internal governance policies, responsibilities, and procedures rather than financial data, earnings, or regulatory filings. There is no indication that this is an annual report, audit report, earnings release, or any other financial report. It is a governance-related document detailing internal rules and structures for accountability within the company. Therefore, the most appropriate classification is Governance Information (CGR). The document length (4926 characters) and detailed procedural content support this classification with high confidence.
2025-11-28 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.